Location History:
- Tokyo-To, JP (2011)
- Tokyo, JP (2014)
Company Filing History:
1 out of 7 
1 out of 1 
1 out of 13 Years Active: 2011-2014
Title: Masaya Ono - Innovator in Monoclonal Antibody Development
Introduction
Masaya Ono, a prominent inventor based in Tokyo, Japan, has made significant strides in the field of biotechnology. With a focus on developing high specificity monoclonal antibodies, Ono has contributed to advancements that hold promise for medical applications, particularly in cancer treatment.
Latest Patents
Ono holds a patent for a "High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification." This invention provides an antibody that reacts specifically with FGA or a partial peptide of FGA, where certain proline residues are hydroxylated, while showing no reaction with unmodified FGA. This specificity could lead to breakthroughs in targeted therapies.
Career Highlights
Masaya Ono has worked with notable organizations including Transgenic Inc. and served as the President of the National Cancer Center. His leadership roles have allowed him to steer research efforts that prioritize innovative solutions to complex medical challenges.
Collaborations
Throughout his career, Ono has collaborated with distinguished colleagues such as Hiroshi Nose and Tomoyo Hashiguchi. These partnerships have enabled a blend of expertise that enhances the quality and impact of his research.
Conclusion
Masaya Ono stands out as a dedicated inventor whose work in the field of monoclonal antibodies showcases the intersection of innovation and medicine. With a focus on specificity, his contributions are paving the way for future advancements in cancer treatment and beyond.